{"nct_id":"NCT06040099","title":"A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-02-13","start_date_type":"ACTUAL","primary_completion_date":"2026-10-23","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-23","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}